EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nutraceutical Capsules LL1 and Silymarin Supplementation Act on Mood and Sleep Quality Perception by Microbiota–Gut–Brain Axis: A Pilot Clinical Study

Aline Boveto Santamarina iD, Victor Nehmi Filho, Jéssica Alves de Freitas iD, Lucas Augusto Moysés Franco iD, Joyce Vanessa Fonseca, Roberta Cristina Martins, José Antônio Orellana Turri iD, Bruna Fernanda Rio Branco da Silva, Arianne Fagotti Gusmão, Eloísa Helena Ribeiro Olivieri, José Pinhata Otoch, Ana Flávia Marçal Pessoa

Nutrients · 2024

DOI: 10.3390/nu16183049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Aline Boveto Santamarina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Produtos e Derivados Naturais, Laboratório de Investigação Médica-26 (LIM-26), Departamento de Cirurgia, Faculdade de Medicina de São …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dietary Supplements, Affect, Silymarin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Efeom Nutrition S.A., Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stress, unhealthy lifestyle, and sleep disturbance worsen cognitive function in mood disorders, prompting a rise in the development of integrative health approaches. The recent investigations in the gut–brain axis field highlight the strong interplay among microbiota, inflammation, and mental health. Thus, this study aimed to investigate a new nutraceutical formulation comprising prebiotics, minerals, and silymarin’s impact on microbiota, inflammation, mood, and sleep quality. The study evaluated the LL1 + silymarin capsule supplementation over 180 days in overweight adults. We analyzed the fecal gut microbiota using partial 16S rRNA sequences, measured cytokine expression via CBA, collected anthropometric data, quality of life, and sleep questionnaire responses, and obtained plasma samples for metabolic and hormonal analysis at baseline (T0) and 180 days (T180) post-supplementation. Our findings revealed significant reshaping in gut microbiota composition at the phylum, genus, and species levels, especially in the butyrate-producer bacteria post-supplementation. These changes in gut microbiota were linked to enhancements in sleep quality, mood perception, cytokine expression, and anthropometric measures which microbiota-derived short-chain fatty acids might enhance. The supplementation tested in this study seems to be able to improve microbiota composition, reflecting anthropometrics and inflammation, as well as sleep quality and mood improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDietary SupplementsAffectSilymarinBrain-Gut AxisSleep QualityHumansPilot ProjectsMaleFemaleAdultMiddle AgedQuality of LifeFecesCapsulesCytokinesOverweightPrebioticsRNA, Ribosomal, 16S

Stichwörter der Autor:innen

dysbiosisgut-brain axisinflammationmicrobiotaprebioticssleep

Substanzen

SilymarinCapsulesCytokinesPrebioticsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Laboratório de Produtos e Derivados Naturais, Laboratório de Investigação Médica-26 (LIM-26), Departamento de Cirurgia, Faculdade de Medicina de São Paulo, Universidade de São Paulo, São Paulo 01246-903, SP, Brazil.
  • Pesquisa e Desenvolvimento Efeom Nutrição S/A, São Paulo 03317-000, SP, Brazil.
  • Laboratório de Parasitologia Médica (LIM-46), Departamento de Doenças Infecciosas e Parasitárias, Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo 05403-000, SP, Brazil.
  • Laboratório de Investigação Médica em Protozoologia, Bacteriologia e Resistência Antimicrobiana (LIM-49), Departamento de Doenças Infecciosas e Parasitárias, Instituto de Medicina Tropical de São Paulo, Universidade de…
  • Grupo de Pesquisa em Economia da Saúde, Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-903, SP, Brazil.
  • Laboratório Interdisciplinar em Fisiologia e Exercício, Universidade Federal de São Paulo (UNIFESP), Santos 11015-020, SP, Brazil.

ORCID-Profile: Aline Boveto Santamarina, Jéssica Alves de Freitas, Lucas Augusto Moysés Franco, José Antônio Orellana Turri

Förderung

  • Efeom Nutrition S.A.
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Santamarina, A. B., Nehmi Filho, V., Freitas, J. A., Franco, L. A. M., Fonseca, J. V., Martins, R. C., Turri, J. A. O., Silva, B. F. R. B. D., Gusmão, A. F., Olivieri, E. H. R., Otoch, J. P., & Pessoa, A. F. M. (2024). Nutraceutical Capsules LL1 and Silymarin Supplementation Act on Mood and Sleep Quality Perception by Microbiota–Gut–Brain Axis: A Pilot Clinical Study. Nutrients. https://doi.org/10.3390/nu16183049

Vancouver

Santamarina AB, Nehmi Filho V, Freitas JA, Franco LAM, Fonseca JV, Martins RC, et al. Nutraceutical Capsules LL1 and Silymarin Supplementation Act on Mood and Sleep Quality Perception by Microbiota–Gut–Brain Axis: A Pilot Clinical Study. Nutrients. 2024. doi:10.3390/nu16183049

BibTeX
@article{Santamarina2024,
  author = {Santamarina, Aline Boveto and Nehmi Filho, Victor and Freitas, Jéssica Alves de and Franco, Lucas Augusto Moysés and Fonseca, Joyce Vanessa and Martins, Roberta Cristina and Turri, José Antônio Orellana and Silva, Bruna Fernanda Rio Branco da and Gusmão, Arianne Fagotti and Olivieri, Eloísa Helena Ribeiro and Otoch, José Pinhata and Pessoa, Ana Flávia Marçal},
  title = {Nutraceutical Capsules LL1 and Silymarin Supplementation Act on Mood and Sleep Quality Perception by Microbiota–Gut–Brain Axis: A Pilot Clinical Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16183049}
}
Kostenlos starten →